Sorry, there was a problem with that video search. Don't worry, we'll fix it shortly!
Search Results
Exploring ESA Treatment Outcomes in Lower-Risk MDS: Expert Perspectives
What to Know About Optimal Luspatercept Use in Lower-Risk MDS
Key highlights in MDS: treating lower-risk & higher-risk disease, trial updates, and more
Imetelstat in patients with lower-risk MDS
Hot Topics on Low-Risk Myelodysplastic Syndromes (MDS) from the 63rd ASH Annual Meeting*
ERN-EuroBloodNet Thursdays Webinars - Treatment of anemia of low risk myelodysplastic syndrome...
Management of Low Risk MDS with Dr. Mikkael Sekeres
Thursday Webinar - Patient stratification in MDS (Treatment of anemia of low risk MDS)
Management of treatment-naïve LR-MDS with isolated 5q deletion (del5q)
What is the goal of treatment? Manage symptoms or cure MDS? #MDS
Management of treatment-naïve LR-MDS
A Unified Approach to Lower Risk MDS: Standard and Emerging Therapies
